“…OCs are composed of synthetic hormones, such as estrogen and progesterone, which can be used isolated (progestogens) or in combination. Estrogen, notably Ethinyl estradiol, may cause important alterations in the hemostatic system, such as the 30-50% increase in the activity of procoagulant factors (factors II, VII, VIII, IX, X, XI, XII, XIII, and fibrinogen) [9], the reduction of natural anticoagulant factors (C-reactive protein, protein S, antithrombin) and the stimulation of endothelial dysfunction, which results in thromboembolic events such as DVT, PTE and CVA [1][2][3]9]. In addition to these hemostatic changes, those combined with higher doses of Ethinyl estradiol, such as the OC used by the patient, develop greater resistance to activated protein C (APC), higher levels of D-dimer, and changes in the lipid profile, such as increased LDL and total cholesterol [8,9].…”